Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
High mobility group nucleosome binding domain 1 pseudogene 17 (HMGN1P17)
- Target
- HMGN1P17
- Molecular classification
- Pseudogene, Other
01
Overview
HMGN1P17 is an intronless human pseudogene that structurally resembles the gene encoding high mobility group nucleosome binding domain 1 (HMGN1). Pseudogenes like HMGN1P17 commonly arise from gene duplication or reverse transcription events and accumulate mutations that prevent expression of a functional protein. These DNA segments may be transcribed at low levels but are generally considered nonfunctional “genetic fossils.” There is no evidence that HMGN1P17 encodes a protein or has a therapeutically relevant function.
- Other names
- HMGN1P17High mobility group nucleosome binding domain 1 pseudogene 17
02
Mechanism of action
None. Not applicable.
03
Biological functions
None as a protein-coding gene; pseudogenes typically do not have direct biological function through a protein product.Some pseudogenes, in rare cases, may have regulatory roles at the RNA level (e.g., microRNA decoys), but there is no evidence for HMGN1P17 specifically
04
Disease associations
None establishedFor some pseudogenes generally, rare regulatory functions have been implicated in cancer and other diseases but only when robust evidence exists; none for HMGN1P17
05
Safety considerations
None. Pseudogenes are not targeted therapeutically and do not pose direct safety concerns.
06
Interacting drugs
None. Not applicable as this pseudogene does not encode a protein and is not a therapeutic target
07
Biomarkers
None known or validated for patient selection, efficacy, or disease monitoring
Beyond the preview
Go deeper on High mobility group nucleosome binding domain 1 pseudogene 17 (HMGN1P17).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on High mobility group nucleosome binding domain 1 pseudogene 17 (HMGN1P17).